Additionally, recent reports described the use of gold nanoparticles for the delivery of clustered regularly interspaced short palindromic repeats CRISPR/Cas9 for the editing of the CXCR4 gene or the dystrophin gene, associated with Duchenne muscular dystrophy (DMD) disease [33]. This evidence concerns the gene CXCR4 and Duchenne muscular dystrophy.